Table V.

High-frequency allele subtypes of control subjects vs. MS patients.

HLA-ABDR allele	Control group frequency, %, n=50	MS group frequency, %, n=50	P-value	Odds ratio	95% confidence interval	Pc
A1	16	13	0.548	1.275	0.578–0.811
A10	7	2	0.169	3.688	0.746–18.211
A25	0	1	1
A26	12	5	0.075	2.591	0.877–7.651
A34	1	0	0.999
A43	2	0	0.490
A66	1	0	0.999
B15	12	5	0.075	2.591	0.877–7.651
B62	0	0	0
B63	0	0	0
B70	0	0	0
B71	0	0	0
B72	0	0	0
B75	0	0	0
B76	0	0	0
B77	0	0	0
B8	11	3	0.026	3.996	1.079–14.791	0.590
DR1	16	10	0.207	1.714	0.737–3.988
DR6	12	7	0.228	1.812	0.68–4.811
DR13	10	5	0.161	2.250	0.709–7.141
DR14	2	2	1	1	0.135–7.392

HLA, human leukocyte antigen; MS, multiple sclerosis; Pc, corrected P-value.